| Dr Debra L Moreland, | |
|
13100 E 136th St, Suite 1200, Fishers, IN 46037-9417 | |
| (317) 678-3100 | |
| (317) 678-3108 |
| Full Name | Dr Debra L Moreland |
|---|---|
| Gender | Female |
| Speciality | Pediatric Medicine |
| Experience | 32 Years |
| Location | 13100 E 136th St, Fishers, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447286547 | NPI | - | NPPES |
| 200041940 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 01041617 (Indiana) | Secondary |
| 207R00000X | Internal Medicine | 01041617 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health | Indianapolis, IN | Hospital |
| Indiana University Health North Hospital | Carmel, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Care Associates Inc | 5799755864 | 882 |
News Archive
Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.
Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.
Ovarian cancer is often detected at a late stage and it is the leading cause of death due to gynecological cancers, and the sixth leading cause of cancer death in women. According to latest discovery by researchers at Sydney's Garvan Institute there may be a way this killer cancer is detected earlier.
'Robert' says a therapy known as PEP, post-exposure prophylaxis, is not widely available and has not been well publicised and he is seeking a judicial review of government policy.
› Verified 5 days ago
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.
Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.
Ovarian cancer is often detected at a late stage and it is the leading cause of death due to gynecological cancers, and the sixth leading cause of cancer death in women. According to latest discovery by researchers at Sydney's Garvan Institute there may be a way this killer cancer is detected earlier.
'Robert' says a therapy known as PEP, post-exposure prophylaxis, is not widely available and has not been well publicised and he is seeking a judicial review of government policy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Debra L Moreland, 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Dr Debra L Moreland, 13100 E 136th St, Suite 1200, Fishers, IN 46037-9417 Ph: (317) 678-3100 |
News Archive
Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.
Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.
Ovarian cancer is often detected at a late stage and it is the leading cause of death due to gynecological cancers, and the sixth leading cause of cancer death in women. According to latest discovery by researchers at Sydney's Garvan Institute there may be a way this killer cancer is detected earlier.
'Robert' says a therapy known as PEP, post-exposure prophylaxis, is not widely available and has not been well publicised and he is seeking a judicial review of government policy.
› Verified 5 days ago
Dr. Michele J Ostrowski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7199 Easy St, Fishers, IN 46038 Phone: 317-415-6110 | |
Tammy N Durham-boring, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 9894 E 121st St, Fishers, IN 46037 Phone: 317-621-6060 Fax: 317-355-6965 | |
Racquel Kukita Reyes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7199 Easy St, Fishers, IN 46038 Phone: 317-415-6110 | |
Anna Marie C Sander, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12677 Brookhaven Dr, Fishers, IN 46037 Phone: 317-219-5188 | |
Dr. Derrick A Williams, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13914 Southeastern Parkway, Suite 210, Fishers, IN 46037 Phone: 317-419-9900 Fax: 317-415-9910 | |
Sridevi A Vedantam, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10318 Copper Ridge Dr, Fishers, IN 46040 Phone: 765-965-6566 | |
Dr. Peter Caccavallo, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13000 E 136th St, Suite 1100, Fishers, IN 46037 Phone: 317-678-3585 Fax: 317-863-5084 |